The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results from a phase I, open-label study of ceralasertib (AZD6738), a novel DNA damage repair agent, in combination with weekly paclitaxel in refractory cancer (NCT02630199).
 
Jeeyun Lee
Consulting or Advisory Role - Oncologie; Seagen
Research Funding - AstraZeneca; Lilly; Merck Sharp & Dohme
 
Seung KIM
No Relationships to Disclose
 
Dr Simon Smith
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Peter G. Mortimer
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Bienvenu Loembé
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Honoraria - AstraZeneca
 
Jung Hong
Research Funding - AstraZeneca
 
Iwanka Kozarewa
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Andrew Pierce
Employment - AstraZeneca/MedImmune
 
Emma Dean
Employment - AstraZeneca/MedImmune
Stock and Other Ownership Interests - AstraZeneca/MedImmune
Travel, Accommodations, Expenses - AstraZeneca